Haven R. Garber

The University of Texas MD Anderson Cancer Center — United States

Immunology and Microbiology · Life Sciences

13h-index672citations103works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(35), Multiple Myeloma Research and Treatments(25), Cancer Genomics and Diagnostics(24), PARP inhibition in cancer therapy(21), Cancer Immunotherapy and Biomarkers(20)

Publications103 total

Abstract PD7-03: Circulating Immune Correlates of Pathological Response to Neoadjuvant Pembrolizumab plus Chemotherapy in High-Risk, Early-Stage Triple-Negative Breast Cancer
Clinical Cancer Research·2026
Abstract GS2-05: Primary Results from the HR+/HER2- Cohort of TBCRC-053 (P-RAD): A Randomized Trial of No, Low, or High Dose Preoperative RADiation with Pembrolizumab and Chemotherapy in Node-Positive, HER2-Negative Breast Cancer
Clinical Cancer Research·2026
Abstract P5-12-09: Pathologic complete response (pCR) rate in patients with a germline pathogenic variant in ATM and early breast cancer
Clinical Cancer Research·2025
Characteristics and outcome of breast cancers diagnosed in patients with germline ATM mutations.
Journal of Clinical Oncology·2025
Evolution of chronic lymphocytic leukemia after allogeneic stem cell transplant
2025Open Access
Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer
International Journal of Radiation Oncology*Biology*Physics·2024· 6 citedOpen Access
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
UNC Libraries·2024Open Access
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer
Oncotarget·2024· 4 citedOpen Access
754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)
Regular and Young Investigator Award Abstracts·2023· 4 citedOpen Access
Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement
Journal of the American College of Surgeons·2023· 1 cited
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
Breast Cancer Research and Treatment·2023· 15 citedOpen Access
Supplementary Figure Legends from Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
2023Open Access
Supplementary Figures 1 through 4 from Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
2023Open Access
Data from Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
2023Open Access
Supplementary Figures 1 through 4 from Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
2023Open Access
Data from Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
2023Open Access
Supplementary Figure Legends from Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells
2023Open Access
Supplementary Figure from Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary <i>BRCA</i> Mutation
2023Open Access
Supplemental Figure S6A from Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma
2023Open Access
Supplemental Figure S9 from Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Elizabeth A. Mittendorf(26), Gheath Alatrash(24), Jeffrey J. Molldrem(20), Lisa S. St. John(19), Karen Clise-Dwyer(18), Jennifer K. Litton(18), Céline Kerros(14), Beatriz E. Adrada(13), Fei Yang(12), Anne V. Philips(12), Edwin R. Parra(12), Banu Arun(12), Pariya Sukhumalchandra(11), Haley L. Peters(11), Jeffrey T. Chang(10), Alexander A. Perakis(10), Madhushree Zope(9), Tapsi Kumar(9), Evthokia Hobbs(9), Alejandro Contreras(9)